RU2009107626A - TRIAZOLE DERIVATIVE AS 11-BETA-HYDROXYSTEROIDDEHYDROGENASE-1 INHIBITORS AND ITS PHARMACEUTICAL COMPOSITION - Google Patents
TRIAZOLE DERIVATIVE AS 11-BETA-HYDROXYSTEROIDDEHYDROGENASE-1 INHIBITORS AND ITS PHARMACEUTICAL COMPOSITION Download PDFInfo
- Publication number
- RU2009107626A RU2009107626A RU2009107626/04A RU2009107626A RU2009107626A RU 2009107626 A RU2009107626 A RU 2009107626A RU 2009107626/04 A RU2009107626/04 A RU 2009107626/04A RU 2009107626 A RU2009107626 A RU 2009107626A RU 2009107626 A RU2009107626 A RU 2009107626A
- Authority
- RU
- Russia
- Prior art keywords
- inhibitors
- beta
- pharmaceutical composition
- pharmaceutically acceptable
- compound according
- Prior art date
Links
Abstract
1. Соединение структурной формулы I: ! ! или его фармацевтически приемлемая соль; ! где R4 представляет собой водород, ! Х представляет собой простую связь, ! R2 представляет собой метил, ! R1 представляет собой фенил, замещенный одним заместителем выбранным из R5, где R5 представляет собой CF3; ! R3 представляет собой метил, замещенный одним заместителем выбранным из R8, где R8 представляет собой (CH2)nS(O)pR6, где каждый n равен 0 и р равно 2, R6 представляет собой С2алкил. ! 2. Фармацевтическая композиция, проявляющая свойства ингибиторов фермента 11-бета-гидроксистероиддегидрогеназы I-го типа, содержащая соединение по п.1, в комбинации с фармацевтически приемлемым носителем. ! 3. Применение соединения по п.1 в получении лекарственного средства, используемого в лечении состояния, выбранного из группы, состоящей из гипергликемии, инсулинорезистентности, диабета 2-го типа, нарушений жирового обмена, ожирения, атеросклероза и метаболического синдрома. 1. The compound of structural formula I:! ! or a pharmaceutically acceptable salt thereof; ! where R4 is hydrogen,! X is a simple bond,! R2 is methyl! R1 is phenyl substituted with one substituent selected from R5, where R5 is CF3; ! R3 is methyl substituted with one substituent selected from R8, where R8 is (CH2) nS (O) pR6, where each n is 0 and p is 2, R6 is C2 alkyl. ! 2. A pharmaceutical composition exhibiting the properties of inhibitors of the enzyme 11-beta-hydroxysteroid dehydrogenase type I, containing the compound according to claim 1, in combination with a pharmaceutically acceptable carrier. ! 3. The use of the compound according to claim 1 in the preparation of a medicament used in the treatment of a condition selected from the group consisting of hyperglycemia, insulin resistance, type 2 diabetes, impaired fat metabolism, obesity, atherosclerosis and metabolic syndrome.
Claims (3)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43507402P | 2002-12-20 | 2002-12-20 | |
US60/435,074 | 2002-12-20 | ||
US45859203P | 2003-03-28 | 2003-03-28 | |
US60/458,592 | 2003-03-28 | ||
US60/503,410 | 2003-09-16 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2005122936/04A Division RU2360910C2 (en) | 2002-12-20 | 2003-12-16 | Triazole derivatives as inhibitors of 11-beta-hydroxysteroiddehydrogenase-1 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2009107626A true RU2009107626A (en) | 2010-09-10 |
Family
ID=35873241
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2005122936/04A RU2360910C2 (en) | 2002-12-20 | 2003-12-16 | Triazole derivatives as inhibitors of 11-beta-hydroxysteroiddehydrogenase-1 |
RU2009107626/04A RU2009107626A (en) | 2002-12-20 | 2009-03-03 | TRIAZOLE DERIVATIVE AS 11-BETA-HYDROXYSTEROIDDEHYDROGENASE-1 INHIBITORS AND ITS PHARMACEUTICAL COMPOSITION |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2005122936/04A RU2360910C2 (en) | 2002-12-20 | 2003-12-16 | Triazole derivatives as inhibitors of 11-beta-hydroxysteroiddehydrogenase-1 |
Country Status (1)
Country | Link |
---|---|
RU (2) | RU2360910C2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY149622A (en) * | 2006-03-22 | 2013-09-13 | Hoffmann La Roche | Pyrazoles as 11-beta-hsd-1 |
-
2003
- 2003-12-16 RU RU2005122936/04A patent/RU2360910C2/en not_active IP Right Cessation
-
2009
- 2009-03-03 RU RU2009107626/04A patent/RU2009107626A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2005122936A (en) | 2006-01-20 |
RU2360910C2 (en) | 2009-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05008600A (en) | Compounds for the treatment of metabolic disorders. | |
CY1111310T1 (en) | UNIONS FOR THE TREATMENT OF METABOLIC DISORDERS | |
HK1083462A1 (en) | Compounds for the treatment of metabolic disorders | |
RU2003132687A (en) | TREATMENT OF TYPE 2 DIABETES BY DIPEPTIDYLPEPTIDASE IV INHIBITORS | |
CA2566945A1 (en) | Pyrazole derivatives, compositions containing such compounds and methods of use | |
CA2445346A1 (en) | N-substituted pyrazole-o-glycoside derivatives and therapeutic agent for diabetes containing the same | |
ATE526018T1 (en) | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS | |
RU2008123000A (en) | COMPOUNDS FOR TREATMENT OF METABOLIC DISORDERS | |
HUP0402403A2 (en) | Dipeptidyl peptidase iv (dp-iv) inhibitors anti-diabetic agents pharmaceutical compositions coutaining thereof and their use | |
RU2008142261A (en) | PHARMACEUTICAL COMPOSITION WITH MODIFIED RELEASE AND ITS APPLICATION | |
RU2008133654A (en) | METHOD AND MEDICINE FOR TREATMENT OF SEVERE HEART FAILURE | |
SE9904421D0 (en) | New compounds | |
KR890014534A (en) | Thiazolidinedione derivatives as blood sugar reducing agents | |
ATE540675T1 (en) | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS | |
UA88772C2 (en) | Compounds for the treatment of metabolic disorders | |
RU2008129623A (en) | CCR9 ACTIVITY INHIBITORS | |
CA2575521A1 (en) | Medicinal composition containing diabetes remedy | |
RU2009107626A (en) | TRIAZOLE DERIVATIVE AS 11-BETA-HYDROXYSTEROIDDEHYDROGENASE-1 INHIBITORS AND ITS PHARMACEUTICAL COMPOSITION | |
HUT59124A (en) | Process for producing 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxane derivatives and pharmaceutical compositions comprising such derivatives as active ingredient | |
KR930012698A (en) | β-oxo-β-benzenepropanethioamide derivative | |
GEP20043240B (en) | Novel Thiazolidinedione Derivatives as Antidiabetic Agents, Methods for their Production and Pharmaceutical Composition Containing the Same | |
RU2005124286A (en) | Oligosaccharide Derivative | |
SE0400285D0 (en) | Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof | |
SE9904416D0 (en) | Crystalline form |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20120406 |